Skip to main content
. 2022 Apr 25;7:21. doi: 10.21037/tgh.2020.03.09

Table 3. Serious adverse events in ESG in 1,607 cases (59).

Adverse event Events (%)
Intraabdominal collection 7 (0.4)
Hemorrhage requiring intervention 6 (0.4)
Refractory symptoms requiring reversal 3 (0.2)
Pneumoperitoneum/pneumothorax 1 (0.1)
Pulmonary embolism 1 (0.1)
Perforation or death 0

ESG, endoscopic sleeve gastroplasty.